Unadjusted and adjusted hazard of (A) end-stage kidney disease: renal replacement therapy; (B) major adverse cardiovascular and cerebral events; and (C) all-cause death, by alkaline phosphatase-to-albumin ratio levels (continuous/categorical variable). The gene discussed is ALB; the disease is kidney disorder.